The present invention provides pharmaceutical formulations comprising a human antibody that specifically binds to human interleukin-4 receptor (hIL-4R). The formulations may contain, in addition to an anti-hIL-4R antibody, at least one amino acid, at least one sugar, or at least one non-ionic surfactant. The pharmaceutical formulations of the present invention exhibit a substantial degree of antibody stability after storage for several months.本發明提供一種包含能特異性地結合人介白素-4受體(hIL-4R)之人類抗體的醫藥配製物。除了抗-hIL-4R抗體之外，該配製物可含有至少一種胺基酸、至少一種糖類，或至少一種非離子表面活性劑。本發明之醫藥配製物於儲存數個月之後能展現一實質程度的抗體穩定性。
